Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 29, 2026Journal of NanobiotechnologyOpen Access

An inflammation-modulating ferroptotic nanoplatform for immune-compatible cancer therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

QCQing ChenQCQing ChenSTShanyou Tong

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates enhanced antitumor efficacy by combining ferroptosis induction with inflammation modulation in tumor environments, suggesting new cancer therapy strategies.

Key Points

  • The aim is to develop a therapeutic platform that induces ferroptosis while modulating inflammation to enhance immune response against tumors.
  • Developed an iron-coordinated mesoporous polydopamine carrier (mPDA–Fe–Cel) combined with celastrol.
  • Utilized 808-nm photothermal heating and iron redox cycling to induce ferroptosis in tumor cells.
  • Conducted transcriptomic and protein-level analyses of inflammatory signaling pathways.
  • mPDA–Fe–Cel increased labile Fe²⁺ and lipid peroxidation, resulting in enhanced ferroptosis in tumor cells.
  • Attenuated NF-κB inflammatory programs were observed, leading to reduced activation of TLR and NLR pathways.
  • Enhanced DC maturation and CD8⁺ T-cell infiltration were noted, improving antitumor efficacy in murine models.

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/6a420b08f91bb43ea919235fhttps://doi.org/10.1186/s12951-026-04742-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Dual-Regulated Nanodrug Potentiates Immunotherapy by Synergizing Ferroptosis with Radiotherapy to Reverse the Immunosuppressive Tumor Microenvironment2025
  2. 2A bioinspired catalytic nanoplatform for ferroptosis‐immunotherapy synergy in metastatic cancer2026
  3. 3Synergistic Ferroptosis–Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization2025 · 29 citations
  4. 4Cell Membrane‐Engineered FePDA Nanoparticles Integrate Ferroptosis and Antitumor Immunity2026
  5. 5Ferroptotic tumor cells reprogram tumor-associated macrophage antigen presentation to enhance the efficacy of immune checkpoint blockade.2026 · 1 citations